nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—HTR1B—obesity	0.112	0.333	CbGaD
Ergotamine—HTR2C—obesity	0.0916	0.271	CbGaD
Ergotamine—DRD2—obesity	0.0755	0.223	CbGaD
Ergotamine—HTR2A—obesity	0.0583	0.173	CbGaD
Ergotamine—SLC6A2—Diethylpropion—obesity	0.0451	0.0909	CbGbCtD
Ergotamine—ADRA1B—Phendimetrazine—obesity	0.0374	0.0755	CbGbCtD
Ergotamine—SLC6A2—Sibutramine—obesity	0.0342	0.0689	CbGbCtD
Ergotamine—SLC6A2—Phendimetrazine—obesity	0.0342	0.0689	CbGbCtD
Ergotamine—ADRA1A—Phendimetrazine—obesity	0.0295	0.0595	CbGbCtD
Ergotamine—ADRA2B—Methamphetamine—obesity	0.0268	0.0541	CbGbCtD
Ergotamine—SLC6A2—Benzphetamine—obesity	0.0259	0.0522	CbGbCtD
Ergotamine—SLC6A2—Phentermine—obesity	0.0259	0.0522	CbGbCtD
Ergotamine—SLC6A2—Phenylpropanolamine—obesity	0.0247	0.0498	CbGbCtD
Ergotamine—ADRA2A—Benzphetamine—obesity	0.0233	0.0471	CbGbCtD
Ergotamine—ADRA1A—Benzphetamine—obesity	0.0224	0.0451	CbGbCtD
Ergotamine—ADRA2A—Phenylpropanolamine—obesity	0.0223	0.0449	CbGbCtD
Ergotamine—SLC6A2—Bupropion—obesity	0.022	0.0444	CbGbCtD
Ergotamine—ADRA1A—Phenylpropanolamine—obesity	0.0214	0.043	CbGbCtD
Ergotamine—SLC6A2—Methamphetamine—obesity	0.0207	0.0417	CbGbCtD
Ergotamine—ADRA2A—Methamphetamine—obesity	0.0187	0.0376	CbGbCtD
Ergotamine—CYP1A2—Phentermine—obesity	0.00942	0.019	CbGbCtD
Ergotamine—CYP1A2—Phenylpropanolamine—obesity	0.00899	0.0181	CbGbCtD
Ergotamine—CYP1A2—Bupropion—obesity	0.00801	0.0162	CbGbCtD
Ergotamine—CYP3A4—Sibutramine—obesity	0.00651	0.0131	CbGbCtD
Ergotamine—CYP1A2—Cimetidine—obesity	0.00588	0.0119	CbGbCtD
Ergotamine—ABCB1—Cimetidine—obesity	0.00514	0.0104	CbGbCtD
Ergotamine—CYP3A4—Benzphetamine—obesity	0.00494	0.00995	CbGbCtD
Ergotamine—CYP3A4—Bupropion—obesity	0.0042	0.00846	CbGbCtD
Ergotamine—Emotional distress—Diethylpropion—obesity	0.00377	0.122	CcSEcCtD
Ergotamine—CYP3A4—Orlistat—obesity	0.00342	0.0069	CbGbCtD
Ergotamine—CYP3A4—Cimetidine—obesity	0.00308	0.00621	CbGbCtD
Ergotamine—SLC6A2—sympathetic nervous system—obesity	0.00228	0.112	CbGeAlD
Ergotamine—CYP3A4—Topiramate—obesity	0.00202	0.00407	CbGbCtD
Ergotamine—SLC6A2—autonomic nervous system—obesity	0.00153	0.075	CbGeAlD
Ergotamine—Peripheral coldness—Bupropion—obesity	0.00149	0.0484	CcSEcCtD
Ergotamine—HTR2A—sympathetic nervous system—obesity	0.00137	0.067	CbGeAlD
Ergotamine—HTR2A—vagus nerve—obesity	0.00133	0.0649	CbGeAlD
Ergotamine—Peripheral coldness—Topiramate—obesity	0.000951	0.0309	CcSEcCtD
Ergotamine—HTR2A—autonomic nervous system—obesity	0.000921	0.0451	CbGeAlD
Ergotamine—Tachycardia—Methamphetamine—obesity	0.000893	0.029	CcSEcCtD
Ergotamine—Tachycardia—Benzphetamine—obesity	0.000862	0.028	CcSEcCtD
Ergotamine—Tachycardia—Phendimetrazine—obesity	0.000785	0.0255	CcSEcCtD
Ergotamine—Bradycardia—Cimetidine—obesity	0.00078	0.0253	CcSEcCtD
Ergotamine—Hypertension—Phentermine—obesity	0.000696	0.0226	CcSEcCtD
Ergotamine—Tachycardia—Phenylpropanolamine—obesity	0.000671	0.0218	CcSEcCtD
Ergotamine—HTR1A—hindbrain—obesity	0.000651	0.0318	CbGeAlD
Ergotamine—Tachycardia—Phentermine—obesity	0.000642	0.0208	CcSEcCtD
Ergotamine—ADRA1A—hindbrain—obesity	0.0006	0.0294	CbGeAlD
Ergotamine—Myalgia—Diethylpropion—obesity	0.000597	0.0194	CcSEcCtD
Ergotamine—DRD2—hindbrain—obesity	0.000589	0.0288	CbGeAlD
Ergotamine—Myalgia—Cimetidine—obesity	0.000568	0.0184	CcSEcCtD
Ergotamine—Tachycardia—Diethylpropion—obesity	0.000558	0.0181	CcSEcCtD
Ergotamine—Tachycardia—Cimetidine—obesity	0.000531	0.0172	CcSEcCtD
Ergotamine—Nausea—Benzphetamine—obesity	0.000524	0.017	CcSEcCtD
Ergotamine—Sensory loss—Topiramate—obesity	0.000523	0.017	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000521	0.0169	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Cimetidine—obesity	0.000496	0.0161	CcSEcCtD
Ergotamine—Nausea—Phendimetrazine—obesity	0.000478	0.0155	CcSEcCtD
Ergotamine—Asthenia—Phentermine—obesity	0.000472	0.0153	CcSEcCtD
Ergotamine—Vomiting—Phenylpropanolamine—obesity	0.000437	0.0142	CcSEcCtD
Ergotamine—Vomiting—Phentermine—obesity	0.000418	0.0136	CcSEcCtD
Ergotamine—Bradycardia—Sibutramine—obesity	0.000417	0.0135	CcSEcCtD
Ergotamine—Nausea—Phenylpropanolamine—obesity	0.000408	0.0132	CcSEcCtD
Ergotamine—Hypoaesthesia—Sibutramine—obesity	0.000407	0.0132	CcSEcCtD
Ergotamine—SLC6A2—respiratory system—obesity	0.000394	0.0193	CbGeAlD
Ergotamine—Nausea—Phentermine—obesity	0.000391	0.0127	CcSEcCtD
Ergotamine—Asthenia—Cimetidine—obesity	0.000391	0.0127	CcSEcCtD
Ergotamine—HTR2A—hindbrain—obesity	0.000388	0.019	CbGeAlD
Ergotamine—HTR1B—cardiovascular system—obesity	0.000378	0.0185	CbGeAlD
Ergotamine—HTR2B—adrenal cortex—obesity	0.000373	0.0182	CbGeAlD
Ergotamine—Ergoloid mesylate—DRD1—obesity	0.000368	0.0935	CrCbGaD
Ergotamine—HTR1D—cardiovascular system—obesity	0.000366	0.0179	CbGeAlD
Ergotamine—Vomiting—Diethylpropion—obesity	0.000364	0.0118	CcSEcCtD
Ergotamine—DRD2—respiratory system—obesity	0.000359	0.0176	CbGeAlD
Ergotamine—Hypoaesthesia—Bupropion—obesity	0.000355	0.0115	CcSEcCtD
Ergotamine—Vomiting—Cimetidine—obesity	0.000346	0.0112	CcSEcCtD
Ergotamine—HTR2B—cardiovascular system—obesity	0.00034	0.0166	CbGeAlD
Ergotamine—Nausea—Diethylpropion—obesity	0.00034	0.011	CcSEcCtD
Ergotamine—ADRA1D—endocrine gland—obesity	0.000335	0.0164	CbGeAlD
Ergotamine—Vertigo—Orlistat—obesity	0.000331	0.0107	CcSEcCtD
Ergotamine—Nausea—Cimetidine—obesity	0.000323	0.0105	CcSEcCtD
Ergotamine—Vertigo—Sibutramine—obesity	0.00032	0.0104	CcSEcCtD
Ergotamine—Myalgia—Orlistat—obesity	0.000314	0.0102	CcSEcCtD
Ergotamine—Hypertension—Sibutramine—obesity	0.000308	0.00999	CcSEcCtD
Ergotamine—HTR1A—cardiovascular system—obesity	0.000305	0.0149	CbGeAlD
Ergotamine—Myalgia—Sibutramine—obesity	0.000303	0.00985	CcSEcCtD
Ergotamine—CYP1A2—respiratory system—obesity	0.000303	0.0148	CbGeAlD
Ergotamine—HTR2B—adipose tissue—obesity	0.0003	0.0147	CbGeAlD
Ergotamine—ADRA2A—islet of Langerhans—obesity	0.000295	0.0144	CbGeAlD
Ergotamine—Dihydroergotamine—HTR1B—obesity	0.000292	0.0744	CrCbGaD
Ergotamine—Tachycardia—Sibutramine—obesity	0.000284	0.00921	CcSEcCtD
Ergotamine—HTR2B—digestive system—obesity	0.000282	0.0138	CbGeAlD
Ergotamine—ADRA1A—cardiovascular system—obesity	0.000281	0.0137	CbGeAlD
Ergotamine—Vertigo—Bupropion—obesity	0.000279	0.00906	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Orlistat—obesity	0.000274	0.00889	CcSEcCtD
Ergotamine—Paraesthesia—Orlistat—obesity	0.00027	0.00876	CcSEcCtD
Ergotamine—HTR2B—adrenal gland—obesity	0.000269	0.0131	CbGeAlD
Ergotamine—Hypertension—Bupropion—obesity	0.000268	0.00871	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Sibutramine—obesity	0.000265	0.0086	CcSEcCtD
Ergotamine—Myalgia—Bupropion—obesity	0.000265	0.00858	CcSEcCtD
Ergotamine—Paraesthesia—Sibutramine—obesity	0.000261	0.00848	CcSEcCtD
Ergotamine—Ergoloid mesylate—DRD2—obesity	0.000259	0.0659	CrCbGaD
Ergotamine—HTR1B—endocrine gland—obesity	0.000259	0.0127	CbGeAlD
Ergotamine—Pain—Orlistat—obesity	0.000257	0.00834	CcSEcCtD
Ergotamine—Pain—Sibutramine—obesity	0.000249	0.00807	CcSEcCtD
Ergotamine—ADRA1A—adipose tissue—obesity	0.000248	0.0121	CbGeAlD
Ergotamine—Tachycardia—Bupropion—obesity	0.000247	0.00803	CcSEcCtD
Ergotamine—DRD2—pituitary gland—obesity	0.000244	0.0119	CbGeAlD
Ergotamine—HTR1A—adrenal gland—obesity	0.000241	0.0118	CbGeAlD
Ergotamine—SLC6A2—adrenal gland—obesity	0.000239	0.0117	CbGeAlD
Ergotamine—HTR2A—respiratory system—obesity	0.000237	0.0116	CbGeAlD
Ergotamine—Bradycardia—Topiramate—obesity	0.000232	0.00751	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Bupropion—obesity	0.000231	0.0075	CcSEcCtD
Ergotamine—Paraesthesia—Bupropion—obesity	0.000228	0.00739	CcSEcCtD
Ergotamine—Hypoaesthesia—Topiramate—obesity	0.000226	0.00734	CcSEcCtD
Ergotamine—Methylergometrine—DRD1—obesity	0.000223	0.0567	CrCbGaD
Ergotamine—ADRA1A—adrenal gland—obesity	0.000222	0.0109	CbGeAlD
Ergotamine—Ergonovine—HTR2C—obesity	0.000218	0.0555	CrCbGaD
Ergotamine—Pain—Bupropion—obesity	0.000217	0.00704	CcSEcCtD
Ergotamine—Asthenia—Orlistat—obesity	0.000216	0.007	CcSEcCtD
Ergotamine—Pruritus—Orlistat—obesity	0.000213	0.0069	CcSEcCtD
Ergotamine—HTR1A—endocrine gland—obesity	0.000209	0.0102	CbGeAlD
Ergotamine—Asthenia—Sibutramine—obesity	0.000209	0.00677	CcSEcCtD
Ergotamine—SLC6A2—endocrine gland—obesity	0.000207	0.0101	CbGeAlD
Ergotamine—Pruritus—Sibutramine—obesity	0.000206	0.00668	CcSEcCtD
Ergotamine—Methysergide—HTR1B—obesity	0.000195	0.0496	CrCbGaD
Ergotamine—CYP1A2—digestive system—obesity	0.000193	0.00943	CbGeAlD
Ergotamine—ADRA1A—endocrine gland—obesity	0.000193	0.00942	CbGeAlD
Ergotamine—Vomiting—Orlistat—obesity	0.000191	0.0062	CcSEcCtD
Ergotamine—Methylergometrine—HTR2C—obesity	0.00019	0.0485	CrCbGaD
Ergotamine—ADRA2A—pituitary gland—obesity	0.000189	0.00924	CbGeAlD
Ergotamine—DRD2—endocrine gland—obesity	0.000189	0.00923	CbGeAlD
Ergotamine—ADRA2A—adipose tissue—obesity	0.000188	0.00921	CbGeAlD
Ergotamine—Vomiting—Sibutramine—obesity	0.000185	0.006	CcSEcCtD
Ergotamine—Asthenia—Bupropion—obesity	0.000182	0.0059	CcSEcCtD
Ergotamine—HTR2A—cardiovascular system—obesity	0.000182	0.00888	CbGeAlD
Ergotamine—Pruritus—Bupropion—obesity	0.000179	0.00582	CcSEcCtD
Ergotamine—Nausea—Orlistat—obesity	0.000179	0.00579	CcSEcCtD
Ergotamine—Vertigo—Topiramate—obesity	0.000178	0.00577	CcSEcCtD
Ergotamine—Lisuride—DRD4—obesity	0.000176	0.0449	CrCbGaD
Ergotamine—ADRA1A—liver—obesity	0.000174	0.00849	CbGeAlD
Ergotamine—Nausea—Sibutramine—obesity	0.000173	0.00561	CcSEcCtD
Ergotamine—Hypertension—Topiramate—obesity	0.000171	0.00555	CcSEcCtD
Ergotamine—ADRA2A—adrenal gland—obesity	0.000169	0.00826	CbGeAlD
Ergotamine—Myalgia—Topiramate—obesity	0.000169	0.00547	CcSEcCtD
Ergotamine—ABCB1—islet of Langerhans—obesity	0.000165	0.00804	CbGeAlD
Ergotamine—Bromocriptine—DRD4—obesity	0.000163	0.0416	CrCbGaD
Ergotamine—Vomiting—Bupropion—obesity	0.000161	0.00523	CcSEcCtD
Ergotamine—HTR2A—pituitary gland—obesity	0.000161	0.00786	CbGeAlD
Ergotamine—CYP1A2—endocrine gland—obesity	0.000159	0.00779	CbGeAlD
Ergotamine—Methysergide—HTR2C—obesity	0.000159	0.0405	CrCbGaD
Ergotamine—Tachycardia—Topiramate—obesity	0.000158	0.00512	CcSEcCtD
Ergotamine—Lisuride—HTR1B—obesity	0.000157	0.0399	CrCbGaD
Ergotamine—ABCB1—respiratory system—obesity	0.000155	0.0076	CbGeAlD
Ergotamine—HTR2A—digestive system—obesity	0.000151	0.00737	CbGeAlD
Ergotamine—Nausea—Bupropion—obesity	0.000151	0.00489	CcSEcCtD
Ergotamine—Lisuride—DRD1—obesity	0.000149	0.038	CrCbGaD
Ergotamine—Musculoskeletal discomfort—Topiramate—obesity	0.000147	0.00478	CcSEcCtD
Ergotamine—ADRA2A—endocrine gland—obesity	0.000146	0.00716	CbGeAlD
Ergotamine—Bromocriptine—HTR1B—obesity	0.000145	0.0369	CrCbGaD
Ergotamine—Paraesthesia—Topiramate—obesity	0.000145	0.00471	CcSEcCtD
Ergotamine—HTR2A—adrenal gland—obesity	0.000144	0.00702	CbGeAlD
Ergotamine—CYP1A2—liver—obesity	0.000144	0.00702	CbGeAlD
Ergotamine—CYP3A4—digestive system—obesity	0.00014	0.00682	CbGeAlD
Ergotamine—Lisuride—ADRB1—obesity	0.000139	0.0353	CrCbGaD
Ergotamine—Bromocriptine—DRD1—obesity	0.000138	0.0352	CrCbGaD
Ergotamine—Pain—Topiramate—obesity	0.000138	0.00448	CcSEcCtD
Ergotamine—ABCB1—adrenal cortex—obesity	0.00013	0.00637	CbGeAlD
Ergotamine—Bromocriptine—ADRB1—obesity	0.000128	0.0327	CrCbGaD
Ergotamine—Lisuride—HTR2C—obesity	0.000128	0.0325	CrCbGaD
Ergotamine—HTR2A—endocrine gland—obesity	0.000125	0.00609	CbGeAlD
Ergotamine—Methylergometrine—HTR2A—obesity	0.000121	0.0309	CrCbGaD
Ergotamine—ABCB1—cardiovascular system—obesity	0.000119	0.00582	CbGeAlD
Ergotamine—Bromocriptine—HTR2C—obesity	0.000118	0.0301	CrCbGaD
Ergotamine—Asthenia—Topiramate—obesity	0.000116	0.00376	CcSEcCtD
Ergotamine—CYP3A4—endocrine gland—obesity	0.000115	0.00564	CbGeAlD
Ergotamine—Pruritus—Topiramate—obesity	0.000114	0.00371	CcSEcCtD
Ergotamine—HTR2A—liver—obesity	0.000112	0.00549	CbGeAlD
Ergotamine—ABCB1—pituitary gland—obesity	0.000105	0.00515	CbGeAlD
Ergotamine—Lisuride—DRD2—obesity	0.000105	0.0268	CrCbGaD
Ergotamine—ABCB1—adipose tissue—obesity	0.000105	0.00513	CbGeAlD
Ergotamine—CYP3A4—liver—obesity	0.000104	0.00508	CbGeAlD
Ergotamine—Vomiting—Topiramate—obesity	0.000103	0.00333	CcSEcCtD
Ergotamine—Methysergide—HTR2A—obesity	0.000101	0.0258	CrCbGaD
Ergotamine—ABCB1—digestive system—obesity	9.88e-05	0.00483	CbGeAlD
Ergotamine—Bromocriptine—DRD2—obesity	9.75e-05	0.0248	CrCbGaD
Ergotamine—Nausea—Topiramate—obesity	9.6e-05	0.00311	CcSEcCtD
Ergotamine—ABCB1—adrenal gland—obesity	9.41e-05	0.0046	CbGeAlD
Ergotamine—ABCB1—endocrine gland—obesity	8.16e-05	0.00399	CbGeAlD
Ergotamine—Lisuride—HTR2A—obesity	8.14e-05	0.0207	CrCbGaD
Ergotamine—Bromocriptine—HTR2A—obesity	7.54e-05	0.0192	CrCbGaD
Ergotamine—ABCB1—liver—obesity	7.36e-05	0.0036	CbGeAlD
Ergotamine—CYP1A2—Metabolism—COMT—obesity	1.13e-06	1.02e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SERPINE1—obesity	1.13e-06	1.02e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MTOR—obesity	1.13e-06	1.02e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PIK3CB—obesity	1.13e-06	1.02e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PIK3CD—obesity	1.12e-06	1.01e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARA—obesity	1.12e-06	1.01e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GOT2—obesity	1.12e-06	1.01e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—obesity	1.11e-06	1e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARGC1A—obesity	1.11e-06	1e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GNB3—obesity	1.11e-06	1e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	1.11e-06	1e-05	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.11e-06	1e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SERPINE1—obesity	1.11e-06	1e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—HMOX1—obesity	1.11e-06	9.99e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—POMC—obesity	1.1e-06	9.96e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—INS—obesity	1.1e-06	9.91e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.1e-06	9.9e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MAPK8—obesity	1.1e-06	9.9e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TYK2—obesity	1.1e-06	9.89e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—obesity	1.09e-06	9.87e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—FASN—obesity	1.09e-06	9.86e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MYC—obesity	1.09e-06	9.82e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—BCHE—obesity	1.09e-06	9.82e-06	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.09e-06	9.81e-06	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.09e-06	9.81e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RHOA—obesity	1.09e-06	9.81e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—obesity	1.09e-06	9.8e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.09e-06	9.79e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AGT—obesity	1.08e-06	9.79e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GNAS—obesity	1.08e-06	9.77e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—obesity	1.08e-06	9.75e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TYK2—obesity	1.08e-06	9.73e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—STAT3—obesity	1.08e-06	9.72e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MTOR—obesity	1.08e-06	9.72e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PIK3CB—obesity	1.08e-06	9.72e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PIK3R1—obesity	1.08e-06	9.7e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOS3—obesity	1.08e-06	9.7e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—obesity	1.07e-06	9.66e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RHOA—obesity	1.07e-06	9.65e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MYC—obesity	1.07e-06	9.62e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—obesity	1.06e-06	9.59e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PIK3CB—obesity	1.06e-06	9.59e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—obesity	1.06e-06	9.59e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1—obesity	1.06e-06	9.58e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT2—obesity	1.06e-06	9.58e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOB—obesity	1.06e-06	9.56e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PIK3R1—obesity	1.06e-06	9.55e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOS3—obesity	1.06e-06	9.55e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TYK2—obesity	1.06e-06	9.53e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—obesity	1.05e-06	9.5e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CAV1—obesity	1.05e-06	9.5e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOA1—obesity	1.05e-06	9.48e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP2E1—obesity	1.05e-06	9.48e-06	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—obesity	1.05e-06	9.47e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RHOA—obesity	1.05e-06	9.45e-06	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—obesity	1.04e-06	9.42e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NQO1—obesity	1.04e-06	9.37e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.04e-06	9.35e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOS3—obesity	1.04e-06	9.35e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—obesity	1.03e-06	9.32e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—obesity	1.03e-06	9.28e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—PIK3CA—obesity	1.02e-06	9.24e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.02e-06	9.2e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—obesity	1.02e-06	9.19e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LPL—obesity	1.01e-06	9.13e-06	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.01e-06	9.11e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.01e-06	9.1e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—PIK3CA—obesity	1.01e-06	9.1e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—STAT3—obesity	1e-06	9.05e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MYC—obesity	1e-06	9.03e-06	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—obesity	1e-06	9.02e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—obesity	9.99e-07	9.01e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GCG—obesity	9.96e-07	8.98e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC2A4—obesity	9.96e-07	8.98e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PIK3CB—obesity	9.93e-07	8.96e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MTOR—obesity	9.93e-07	8.96e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MAPK8—obesity	9.9e-07	8.93e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GPX1—obesity	9.88e-07	8.91e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—obesity	9.88e-07	8.91e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	9.87e-07	8.91e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—obesity	9.84e-07	8.88e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—obesity	9.83e-07	8.87e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYCS—obesity	9.83e-07	8.87e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TYK2—obesity	9.81e-07	8.85e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—obesity	9.78e-07	8.82e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PIK3CB—obesity	9.77e-07	8.81e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MTOR—obesity	9.77e-07	8.81e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RHOA—obesity	9.73e-07	8.78e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GOT1—obesity	9.64e-07	8.7e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GGT1—obesity	9.64e-07	8.7e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PIK3R1—obesity	9.63e-07	8.69e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOS3—obesity	9.63e-07	8.69e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CD36—obesity	9.62e-07	8.68e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3CG—obesity	9.59e-07	8.65e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MTOR—obesity	9.57e-07	8.63e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PIK3CB—obesity	9.57e-07	8.63e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MAPK8—obesity	9.56e-07	8.62e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—obesity	9.53e-07	8.6e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MAPK8—obesity	9.51e-07	8.58e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NCOA1—obesity	9.5e-07	8.57e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—obesity	9.48e-07	8.56e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—obesity	9.36e-07	8.45e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP19A1—obesity	9.36e-07	8.45e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—STK11—obesity	9.36e-07	8.45e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MYC—obesity	9.32e-07	8.41e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—obesity	9.3e-07	8.39e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—obesity	9.26e-07	8.35e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PIK3CA—obesity	9.24e-07	8.34e-06	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—obesity	9.22e-07	8.32e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	9.17e-07	8.28e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—POMC—obesity	9.13e-07	8.24e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—obesity	9.11e-07	8.22e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MAPK8—obesity	9.1e-07	8.21e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—INS—obesity	9.08e-07	8.19e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—obesity	9.08e-07	8.19e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—obesity	9.07e-07	8.19e-06	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—obesity	9.07e-07	8.18e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—STAT3—obesity	9.05e-07	8.17e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PIK3CA—obesity	9.05e-07	8.16e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARA—obesity	8.94e-07	8.07e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—obesity	8.93e-07	8.05e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PIK3CB—obesity	8.89e-07	8.02e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MTOR—obesity	8.89e-07	8.02e-06	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—obesity	8.88e-07	8.01e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—obesity	8.74e-07	7.89e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—STAT3—obesity	8.74e-07	7.88e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—COMT—obesity	8.7e-07	7.85e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—STAT3—obesity	8.69e-07	7.84e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AGT—obesity	8.66e-07	7.81e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—obesity	8.63e-07	7.79e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GNB3—obesity	8.58e-07	7.74e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARGC1A—obesity	8.58e-07	7.74e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HMOX1—obesity	8.54e-07	7.71e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PIK3CA—obesity	8.5e-07	7.67e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—obesity	8.49e-07	7.66e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—obesity	8.49e-07	7.66e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3CD—obesity	8.43e-07	7.61e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MYC—obesity	8.41e-07	7.59e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CAV1—obesity	8.41e-07	7.58e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MAPK8—obesity	8.39e-07	7.57e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—obesity	8.39e-07	7.57e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOA1—obesity	8.39e-07	7.57e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—obesity	8.37e-07	7.55e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GNAS—obesity	8.36e-07	7.54e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—obesity	8.32e-07	7.51e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—STAT3—obesity	8.32e-07	7.51e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—obesity	8.31e-07	7.5e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MAPK8—obesity	8.26e-07	7.45e-06	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—obesity	8.25e-07	7.44e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—obesity	8.24e-07	7.43e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—obesity	8.18e-07	7.38e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOB—obesity	8.18e-07	7.38e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—obesity	8.12e-07	7.33e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MYC—obesity	8.12e-07	7.33e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—obesity	8.1e-07	7.31e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MAPK8—obesity	8.09e-07	7.3e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MYC—obesity	8.08e-07	7.29e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—obesity	8.06e-07	7.28e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—obesity	8.06e-07	7.27e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.03e-07	7.25e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—obesity	8.01e-07	7.23e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3R1—obesity	7.96e-07	7.18e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NOS3—obesity	7.96e-07	7.18e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PIK3CA—obesity	7.91e-07	7.14e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LPL—obesity	7.81e-07	7.05e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MYC—obesity	7.73e-07	6.98e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—obesity	7.73e-07	6.97e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—obesity	7.72e-07	6.96e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—STAT3—obesity	7.67e-07	6.92e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3CG—obesity	7.66e-07	6.91e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GPX1—obesity	7.62e-07	6.88e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—STAT3—obesity	7.55e-07	6.81e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—obesity	7.55e-07	6.81e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—obesity	7.53e-07	6.79e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MAPK8—obesity	7.51e-07	6.78e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—obesity	7.49e-07	6.76e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CD36—obesity	7.42e-07	6.7e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—obesity	7.39e-07	6.67e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—STAT3—obesity	7.39e-07	6.67e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—obesity	7.39e-07	6.67e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3CB—obesity	7.35e-07	6.63e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—POMC—obesity	7.29e-07	6.58e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—obesity	7.28e-07	6.57e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—INS—obesity	7.25e-07	6.54e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PIK3CA—obesity	7.14e-07	6.44e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MYC—obesity	7.13e-07	6.43e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—obesity	7.11e-07	6.42e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—obesity	7.03e-07	6.35e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MYC—obesity	7.02e-07	6.33e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—obesity	7e-07	6.32e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—obesity	7e-07	6.31e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—obesity	6.94e-07	6.27e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARA—obesity	6.9e-07	6.23e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PIK3CA—obesity	6.89e-07	6.22e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MYC—obesity	6.87e-07	6.2e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—STAT3—obesity	6.87e-07	6.2e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PIK3CA—obesity	6.86e-07	6.19e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—obesity	6.85e-07	6.18e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3CD—obesity	6.73e-07	6.07e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AGT—obesity	6.68e-07	6.03e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—obesity	6.65e-07	6e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PIK3CA—obesity	6.57e-07	5.92e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—obesity	6.55e-07	5.91e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CAV1—obesity	6.49e-07	5.85e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PIK3CA—obesity	6.48e-07	5.85e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOA1—obesity	6.47e-07	5.84e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—obesity	6.46e-07	5.83e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MYC—obesity	6.38e-07	5.76e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—obesity	6.37e-07	5.74e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NOS3—obesity	6.36e-07	5.74e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3R1—obesity	6.36e-07	5.74e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—obesity	6.32e-07	5.71e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—obesity	6.1e-07	5.51e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—obesity	6.07e-07	5.48e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PIK3CA—obesity	6.05e-07	5.46e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PIK3CA—obesity	5.96e-07	5.37e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3CG—obesity	5.91e-07	5.33e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3CB—obesity	5.87e-07	5.29e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—obesity	5.83e-07	5.26e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PIK3CA—obesity	5.83e-07	5.26e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—obesity	5.81e-07	5.25e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—obesity	5.81e-07	5.24e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—obesity	5.7e-07	5.15e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—obesity	5.63e-07	5.08e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—POMC—obesity	5.63e-07	5.08e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—obesity	5.6e-07	5.05e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—INS—obesity	5.59e-07	5.05e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PIK3CA—obesity	5.42e-07	4.89e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—obesity	5.36e-07	4.84e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—obesity	5.36e-07	4.84e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—obesity	5.29e-07	4.78e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—obesity	5.27e-07	4.76e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3CD—obesity	5.2e-07	4.69e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—obesity	5.16e-07	4.66e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—obesity	5.13e-07	4.63e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—obesity	4.94e-07	4.46e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NOS3—obesity	4.91e-07	4.43e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3R1—obesity	4.91e-07	4.43e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—obesity	4.87e-07	4.39e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—obesity	4.8e-07	4.33e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—obesity	4.76e-07	4.3e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3CB—obesity	4.53e-07	4.09e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—obesity	4.49e-07	4.05e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3CA—obesity	4.48e-07	4.04e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—obesity	4.43e-07	3.99e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—obesity	3.66e-07	3.3e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3CA—obesity	3.58e-07	3.23e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—obesity	2.92e-07	2.64e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3CA—obesity	2.76e-07	2.49e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—obesity	2.26e-07	2.03e-06	CbGpPWpGaD
